GLP-1 & MetabolicMW: 4113.6 g/mol
Semaglutide (GLP-1 Receptor Agonist)
A long-acting GLP-1 analog with 94% structural homology to human GLP-1, stabilized against DPP-4 degradation with a C-18 fatty diacid chain.
Biological Mechanism
Selectively binds and activates the GLP-1 receptor, augmenting insulin secretion in a glucose-dependent manner and central appetite regulation.
Common Research Dosing
0.25 mg – 2.4 mg
Reconstitute with ~2 mL BAC water
Storage & Reconstitution
Store reconstituted peptide at 2°C–8°C for up to 6 weeks.
Audited Vendor Rankings
Top Verified Vendors for Semaglutide
Scientific Context: Semaglutide (GLP-1 Receptor Agonist) is referenced strictly for laboratory research, cell culture studies, and in-vitro analytical testing. It is not licensed for human medical or therapeutic use.